These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transcatheter ablation of septal hypertrophy: a promising alternative to surgery in hypertrophic obstructive cardiomyopathy. Keren A; Banai S Isr Med Assoc J; 2002 Feb; 4(2):114-6. PubMed ID: 11875983 [No Abstract] [Full Text] [Related]
3. Alcohol septal ablation and the Brockenbrough-Braunwald phenomenon. Soon CY; Buergler JM Catheter Cardiovasc Interv; 2008 Dec; 72(7):1016-24. PubMed ID: 19021274 [No Abstract] [Full Text] [Related]
4. The management of hypertrophic cardiomyopathy. Seggewiss H; Gleichmann U; Faber L N Engl J Med; 1997 Jul; 337(5):349-50. PubMed ID: 9235504 [No Abstract] [Full Text] [Related]
5. Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment. Kuhn H; Gietzen F; Leuner C; Gerenkamp T Eur Heart J; 1997 May; 18(5):846-51. PubMed ID: 9152655 [TBL] [Abstract][Full Text] [Related]
6. Balloon positioning difficulties during nonsurgical septal reduction therapy in a patient with hypertrophic obstructive cardiomyopathy. Dudek D; Gil R; Dimitrow PP; Legutko J; Pieniazek P; Grodecki J; Przewłocki T; Zmudka K; Tracz W; Dubiel JS Catheter Cardiovasc Interv; 2000 Mar; 49(3):314-7. PubMed ID: 10700065 [TBL] [Abstract][Full Text] [Related]
7. The role of alcohol septal ablation in the treatment of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Elliott P J Am Coll Cardiol; 2011 Nov; 58(22):2329-31. PubMed ID: 22093511 [No Abstract] [Full Text] [Related]
8. A limitation of tachycardia discrimination algorithm in a patient with hypertrophic cardiomyopathy and intermittent complete heart block. Mahajan R; Rohit MK; Bahl A; Talwar KK Pacing Clin Electrophysiol; 2010 Aug; 33(8):1035-7. PubMed ID: 20408964 [No Abstract] [Full Text] [Related]
9. Outcome prediction of septal ablation in patients with hypertrophic cardiomyopathy still a long way to go. Sorajja P; Nishimura RA JACC Cardiovasc Interv; 2011 Sep; 4(9):1035-6. PubMed ID: 21939946 [No Abstract] [Full Text] [Related]
10. Left ventricular outflow tract obstruction in the presence of asymmetric septal hypertrophy and accessory mitral valve tissue treated with alcohol septal ablation. Kim MS; Klein AJ; Groves BM; Quaife RA; Salcedo EE Eur J Echocardiogr; 2008 Sep; 9(5):720-4. PubMed ID: 18490281 [TBL] [Abstract][Full Text] [Related]
11. Management of left ventricular outflow obstruction due to hypertrophic cardiomyopathy. Role of multimodality echocardiographic techniques. Luckie M; Khattar RS Minerva Cardioangiol; 2011 Dec; 59(6):581-9. PubMed ID: 22134470 [TBL] [Abstract][Full Text] [Related]
12. The role of hemodynamic catheterization in the evaluation of hypertrophic obstructive cardiomyopathy: A case series. Bishu K; Coylewright M; Nishimura R Catheter Cardiovasc Interv; 2015 Nov; 86(5):903-12. PubMed ID: 25620326 [TBL] [Abstract][Full Text] [Related]
13. Serial evaluations of myocardial infarct size after alcohol septal ablation in hypertrophic cardiomyopathy and effects of the changes on clinical status and left ventricular outflow pressure gradients. Aqel RA; Hage FG; Zohgbi GJ; Tabereaux PB; Lawson D; Heo J; Perry G; Epstein AE; Dell' Italia LJ; Iskandrian AE Am J Cardiol; 2008 May; 101(9):1328-33. PubMed ID: 18435966 [TBL] [Abstract][Full Text] [Related]
14. A new treatment for hypertrophic cardiomyopathy? Braunwald E Eur Heart J; 1997 May; 18(5):709-10. PubMed ID: 9152637 [No Abstract] [Full Text] [Related]
15. Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Almasood A; Garceau P; Woo A; Rakowski H; Schwartz L; Overgaard CB JACC Cardiovasc Interv; 2011 Sep; 4(9):1030-4. PubMed ID: 21939945 [TBL] [Abstract][Full Text] [Related]
16. Mid-systolic septal deceleration. A new sign of left ventricular outflow tract obstruction obtained by color-coded tissue Doppler echocardiography. Breithardt OA; Stolle B; Franke A; Janssens U; Hanrath P; Kuhn H Z Kardiol; 2003 Dec; 92(12):1003-7. PubMed ID: 14663610 [TBL] [Abstract][Full Text] [Related]
17. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future. Ommen SR; Shah PM; Tajik AJ Heart; 2008 Oct; 94(10):1276-81. PubMed ID: 18653577 [No Abstract] [Full Text] [Related]
18. Septal alcoholization in hypertrophic cardiomyopathy: about 11 cases. Kambiré Y; Millogo GRC; Dauphin C; Lusson JR Pan Afr Med J; 2017; 27():196. PubMed ID: 28904721 [TBL] [Abstract][Full Text] [Related]
19. Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. Nagueh SF; Groves BM; Schwartz L; Smith KM; Wang A; Bach RG; Nielsen C; Leya F; Buergler JM; Rowe SK; Woo A; Maldonado YM; Spencer WH J Am Coll Cardiol; 2011 Nov; 58(22):2322-8. PubMed ID: 22093510 [TBL] [Abstract][Full Text] [Related]
20. Long-term consequences of the right ventricular pacing mania of the 1990s for obstructive hypertrophic cardiomyopathy. Maron BJ; Josephson ME Am J Cardiol; 2014 Jan; 113(1):191-2. PubMed ID: 24239321 [No Abstract] [Full Text] [Related] [Next] [New Search]